Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Plast Reconstr Surg ; 147(6): 1039-1049, 2021 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-34019519

RESUMO

BACKGROUND: Despite successful legislative efforts by the American Society of Plastic Surgeons (ASPS), the Plastic Surgery Political Action Committee remains underused. Participation in advocacy and financial contributions of ASPS members fall below those of similar surgical subspecialties. This study aims to perform a data-driven investigation into the impact of Plastic Surgery Political Action Committee efforts on the practicing plastic surgeon. METHODS: A retrospective review of the ASPS procedural database from 1992 to 2018 and Plastic Surgery Political Action Committee contributions from 2012 to 2018 was performed. Postmastectomy breast and congenital anomaly reconstructions were analyzed. To determine significant variations in trends, change-point analyses were conducted. Changes in surgical volume were correlated to implementation of federal legislative efforts. RESULTS: Three significant trends of increased breast reconstruction volume were detected with associations to three specific legislative changes: 1992 to 1998, which correlates with the Women's Health and Cancer Rights Act; 2006 to 2009, which correlates with the U.S. Food and Drug Administration's approval of silicone breast implant use; and 2013 to 2015, which correlates with the Breast Cancer Patient Education Act. During the study period, breast reconstruction procedures increased substantially compared with all reconstructive procedures (146.6 percent versus 3.6 percent). There were no significant trends detected for birth defect reconstructions. Although contributions were relatively stagnant, resident member contributions increased after 2015, correlating with formation of the Political Action Committee's Resident's Club. CONCLUSIONS: This study demonstrates a correlation in timing between Plastic Surgery Political Action Committee legislative accomplishments and the resulting case volume increase in some areas of plastic surgery. The data highlight the importance of political advocacy and how political action committee activities can directly impact patient access to care and the practice of plastic surgery.


Assuntos
Implante Mamário/legislação & jurisprudência , Acessibilidade aos Serviços de Saúde/legislação & jurisprudência , Mastectomia/efeitos adversos , Defesa do Paciente/legislação & jurisprudência , Ativismo Político , Mama/anormalidades , Mama/cirurgia , Neoplasias da Mama/cirurgia , Feminino , Humanos , Estudos Retrospectivos , Sociedades Médicas/organização & administração , Cirurgiões/organização & administração , Cirurgia Plástica/organização & administração , Estados Unidos
2.
Aesthet Surg J ; 34(1): 79-86, 2014 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-24396074

RESUMO

BACKGROUND: Malpractice claims affect the cost and quality of health care. OBJECTIVE: The authors examine litigation in cosmetic breast surgery and identify factors influencing malpractice litigation outcomes. METHODS: The Westlaw database was searched for jury verdict and settlement reports related to medical malpractice and cosmetic breast surgeries. Cases included for analysis were examined for year, geographic location, patient demographics, procedure performed, alleged injury, causes of action, verdict, and indemnity payments. RESULTS: Of 292 cases, the most common injury sustained was disfigurement (53.1%). Negligent misrepresentation had a 98% greater chance of resolution in favor of the plaintiff (relative risk [RR], 1.98; 95% confidence interval [CI], 1.41-2.79), and fraud had a 92% greater chance of disposition in favor of the plaintiff (RR, 1.92; 95% CI, 1.32-2.80). The most common causes of action cited were negligence (88.7%) and lack of informed consent (43.8%). One hundred sixty-nine (58.3%) cases resulted in favor of the defendant and 121 (41.7%) cases were disposed in favor of the plaintiff; 97 (33.4%) cases resulted in damages awarded and 24 (8.3%) cases resulted in settlement. No significant difference was found between the medians of indemnity payments awarded to plaintiffs ($245 000) and settlements ($300 000). CONCLUSIONS: Based on this study, negligent or intentional misrepresentation strongly favors plaintiffs in either awarded damages or settlements in cases of cosmetic breast surgery litigation. This study emphasizes that transparency and adequate communication are at the crux of the physician-patient relationship and are tools by which plastic surgeons may reduce the frequency of litigations, thereby containing health care costs at a minimum.


Assuntos
Implante Mamário/legislação & jurisprudência , Compensação e Reparação/legislação & jurisprudência , Responsabilidade Legal , Mamoplastia/legislação & jurisprudência , Erros Médicos/legislação & jurisprudência , Adolescente , Adulto , Idoso , Implante Mamário/efeitos adversos , Implante Mamário/economia , Feminino , Humanos , Responsabilidade Legal/economia , Masculino , Mamoplastia/efeitos adversos , Mamoplastia/economia , Erros Médicos/efeitos adversos , Erros Médicos/economia , Pessoa de Meia-Idade , Razão de Chances , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA